Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Tree Frog
Generic Name
Comfrey Root, Rosemary
Active Ingredient
Comfrey RootCategory
Non-Standardized Food Allergenic Extract [EPC]
Variants
2
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Tree Frog, you must consult a qualified healthcare professional.
Detailed information about Tree Frog
Comfrey Root is a botanical extract classified primarily as a Non-Standardized Plant Allergenic Extract and Nitrogen Binding Agent. It is used clinically for diagnostic allergenic testing and historically for topical wound healing, though internal use is restricted due to hepatotoxicity.
Because Comfrey Root is not FDA-approved for internal use, there is no established 'Standardized Oral Dose.' Dosage guidelines apply exclusively to topical applications and diagnostic procedures.
For the treatment of acute back pain or joint swelling, clinical studies (such as those involving the proprietary extract BH 131) have utilized the following:
In the context of allergenic testing, the dosage is determined by the allergist based on standardized protocols for skin prick testing (SPT). Typically, a single drop of the extract is applied to the skin, followed by a superficial prick.
Pediatric patients are significantly more susceptible to the hepatotoxic effects of pyrrolizidine alkaloids due to their smaller body mass and developing liver function. While some topical preparations may be used under strict medical supervision for short periods, most healthcare providers advise against its use in children under the age of 18. If a doctor approves use, the duration must be extremely brief (less than 5 days), and the application area must be small.
There are no specific dosage adjustments provided for topical use in patients with kidney disease. However, since metabolites are excreted renally, patients with Stage 4 or 5 Chronic Kidney Disease (CKD) should use topical comfrey with extreme caution and only under medical supervision.
Contraindicated. Patients with any form of liver disease (hepatitis, cirrhosis, fatty liver) should avoid Comfrey Root entirely, even in topical forms, as the liver is the primary target for PA-induced toxicity.
Geriatric patients often have thinner skin (atrophic skin), which may increase the systemic absorption of topically applied substances. Dosage should be conservative, and the skin should be monitored closely for irritation or signs of systemic toxicity.
If you miss a topical application, apply it as soon as you remember. However, if it is almost time for your next application, skip the missed dose and resume your regular schedule. Do not 'double up' the amount applied to make up for a missed dose.
Acute overdose from topical application is rare but can occur with excessive use on broken skin. Signs of pyrrolizidine alkaloid poisoning include:
If accidental ingestion occurs, or if systemic symptoms develop, contact a Poison Control Center (1-800-222-1222 in the US) or seek emergency medical attention immediately. Do not induce vomiting unless instructed to do so by a medical professional.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or extend the duration of treatment without medical guidance.
When used topically as directed, Comfrey Root is generally well-tolerated by most individuals. The most common side effects are localized to the site of application:
Comfrey Root is a pharmacologically active substance that must be handled with extreme caution. The primary safety concern involves its content of pyrrolizidine alkaloids (PAs), which are known to cause irreversible liver damage and cancer in animal models. Patients must understand that 'natural' does not equate to 'safe' in the context of Comfrey Root.
No official FDA black box warning exists as Comfrey Root is not an FDA-approved prescription drug. However, the FDA’s 2001 safety alert carries equivalent clinical weight for healthcare providers. It states that Comfrey Root should never be ingested and that topical use must be strictly limited to intact skin for short durations.
Hepatotoxic Drugs: Comfrey Root should never be used in combination with other medications known to cause liver damage. This includes:
Clinical Consequence
Comfrey Root must NEVER be used in the following circumstances:
Comfrey Root is considered unsafe during pregnancy. Pyrrolizidine alkaloids (PAs) are known to cross the placental barrier. Animal studies have shown that PAs are both teratogenic (causing birth defects) and fetotoxic (toxic to the fetus). There is a significant risk of the fetus developing liver veno-occlusive disease in utero if the mother is exposed to comfrey. Pregnant women should avoid all forms of comfrey, including topical applications, to ensure the safety of the developing fetus.
Avoid Use. PAs are lipophilic (fat-soluble) and can be excreted into human breast milk. Ingesting breast milk contaminated with these alkaloids poses a severe risk of liver damage to the nursing infant, whose liver is not yet fully equipped to detoxify these compounds. The risk-benefit ratio for topical comfrey use during lactation is unfavorable; safer alternatives for pain management should be used.
Comfrey Root exerts its effects through several distinct pathways:
Common questions about Tree Frog
Comfrey Root is primarily used today in two specific medical contexts: as a diagnostic allergenic extract and as a topical treatment for musculoskeletal pain. In allergy clinics, it is used in skin testing to identify sensitivities to certain plant proteins. For pain relief, it is applied as a cream or ointment to treat conditions like back pain, sprains, and minor sports injuries. Its high allantoin content helps soothe skin and promote cell growth. However, it is never used internally due to the risk of severe liver damage and potential cancer.
The most common side effects of Comfrey Root are localized skin reactions at the site of application. These include redness, itching, a mild burning sensation, or a dry, flaky rash known as contact dermatitis. These symptoms usually disappear shortly after the product is washed off. Because it is applied to the skin, systemic side effects are rare if used on intact skin for short periods. However, any signs of skin irritation should be reported to a healthcare provider. If used improperly, more serious internal side effects like liver pain can occur.
It is strongly advised to avoid or significantly limit alcohol consumption while using Comfrey Root, even in topical forms. Both alcohol and the toxic components of Comfrey Root (pyrrolizidine alkaloids) are processed by the liver. Alcohol can increase the activity of liver enzymes that turn comfrey's alkaloids into dangerous toxins. This combination significantly raises the risk of liver injury or hepatotoxicity. To protect your liver health, discuss your alcohol intake with your doctor before using any comfrey-containing products.
No, Comfrey Root is considered unsafe during pregnancy and should be strictly avoided. The pyrrolizidine alkaloids in the plant can cross the placenta and may cause severe liver damage or birth defects in the developing fetus. There is also a risk of causing a rare but fatal liver condition in the unborn baby. Because of these significant risks, pregnant women should not use comfrey in any form, including teas, supplements, or topical creams. Always consult your obstetrician before using any herbal or botanical products during pregnancy.
When applied topically for pain relief, Comfrey Root typically begins to work within 1 to 3 hours. Patients may notice a reduction in swelling and a decrease in pain intensity during this timeframe. The full therapeutic effect for acute injuries like sprains is usually achieved after a few days of consistent application. However, treatment should not exceed 10 consecutive days to prevent the accumulation of toxic alkaloids in the body. If symptoms do not improve within a week, you should consult a healthcare professional for further evaluation.
Yes, you can stop using Comfrey Root suddenly without experiencing withdrawal symptoms. Since it is not an addictive substance or a medication that alters systemic hormones or neurotransmitters, there is no need to taper the dose. However, if you were using it for pain management, your pain or inflammation may return once you stop the applications. If you experience any unusual symptoms like jaundice or abdominal pain after stopping, you should seek medical attention. Always follow the duration limits recommended by your doctor to ensure safety.
If you miss a scheduled topical application of Comfrey Root, apply it as soon as you remember. If it is almost time for your next scheduled application, skip the missed dose and continue with your regular routine. Do not apply extra cream or 'double up' to compensate for the missed dose, as this increases the risk of skin irritation and systemic absorption of toxins. Maintaining a consistent but limited application schedule is the safest way to use the product. If you frequently forget applications, consider setting a reminder on your phone.
Standard topical use of Comfrey Root does not cause typical weight gain associated with fat or muscle changes. However, a very serious side effect of comfrey toxicity is 'ascites,' which is the buildup of fluid in the abdomen due to liver damage. This can cause a sudden, noticeable increase in weight and abdominal girth. If you notice rapid weight gain accompanied by stomach swelling or yellowing of the skin while using comfrey, seek emergency medical help immediately. This is a sign of a medical emergency rather than standard weight gain.
Comfrey Root can interact with several types of medications, particularly those that affect the liver. It should never be used with other hepatotoxic drugs like high-dose acetaminophen or methotrexate. Additionally, drugs that induce the CYP3A4 enzyme, such as certain anti-seizure medications or Rifampin, can make comfrey more toxic. Because of these risks, you must inform your doctor about all prescription drugs, over-the-counter medicines, and herbal supplements you are taking. Using comfrey with other medications requires careful medical oversight to prevent liver injury.
Comfrey Root is a botanical ingredient rather than a patented pharmaceutical drug, so the concept of 'generic' vs. 'brand name' is slightly different. It is available in many over-the-counter topical formulations under various brand names and as generic 'Comfrey Ointment' or 'Symphytum officinale' extract. However, the quality and alkaloid content can vary significantly between manufacturers. It is important to choose products from reputable sources that guarantee the absence of pyrrolizidine alkaloids or specify 'PA-free' on the label. Always consult a pharmacist to select a high-quality, safe formulation.
Other drugs with the same active ingredient (Comfrey Root)
> Warning: Stop taking Comfrey Root and call your doctor immediately if you experience any of these symptoms, which may indicate systemic toxicity or a severe allergic reaction.
Prolonged or repetitive use of Comfrey Root, even topically, carries significant long-term risks due to the cumulative nature of pyrrolizidine alkaloids:
While the FDA does not issue 'Black Box Warnings' for botanical extracts in the same way it does for prescription drugs, the 2001 FDA advisory serves as a de facto highest-level warning.
Report any unusual symptoms to your healthcare provider. If you suspect a side effect is related to Comfrey Root, you may also report it to the FDA MedWatch program.
If a healthcare provider approves the use of Comfrey Root for a patient with a complex medical history, the following monitoring may be required:
Topical Comfrey Root is not known to cause sedation or impair cognitive function. It is generally considered safe to drive or operate machinery while using this product, provided no systemic allergic reactions occur.
Alcohol should be avoided or strictly limited. Both alcohol and Comfrey Root are processed by the liver. Concurrent use can significantly increase the metabolic stress on hepatocytes (liver cells) and may accelerate the conversion of pyrrolizidine alkaloids into their toxic pyrrole forms.
There is no known withdrawal syndrome associated with Comfrey Root. It can be discontinued abruptly. However, if you are using it for pain management, your symptoms may return upon discontinuation. If you experience any signs of liver distress after stopping the medication, consult a doctor immediately, as PA-induced damage can sometimes manifest shortly after exposure ends.
> Important: Discuss all your medical conditions with your healthcare provider before starting Comfrey Root.
CYP3A4 Inducers: These drugs increase the activity of the liver enzyme responsible for turning comfrey’s alkaloids into toxins. Examples include:
Clinical Consequence: These medications 'speed up' the production of toxic pyrroles from comfrey, making even small doses of comfrey significantly more dangerous to the liver.
Anticoagulants and Antiplatelets: Comfrey Root contains small amounts of substances that may theoretically affect blood clotting.
Management: Monitor for increased bruising or bleeding if using topical comfrey over large areas while on blood thinners.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. The risk of liver injury is significantly higher when multiple substances are processed by the same hepatic pathways.
Conditions requiring careful risk-benefit analysis by a physician:
Patients who are allergic to the following may also experience reactions to Comfrey Root:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing or recommending Comfrey Root for any diagnostic or therapeutic purpose.
Elderly patients (65 years and older) should use Comfrey Root with caution. Age-related changes in skin physiology, such as thinning of the dermis and decreased skin barrier function, can lead to increased absorption of topically applied substances. Additionally, many older adults have reduced hepatic blood flow and renal clearance, which can slow the elimination of toxic metabolites. The risk of polypharmacy (taking multiple medications) in the elderly also increases the likelihood of drug-herb interactions, particularly with other hepatotoxic drugs.
In patients with impaired kidney function, the excretion of the polar metabolites of pyrrolizidine alkaloids may be delayed. While no specific GFR (Glomerular Filtration Rate) cut-offs have been established for topical comfrey, patients with a GFR below 30 mL/min/1.73m² should be monitored closely for signs of systemic toxicity. Comfrey is not known to be cleared by hemodialysis.
Contraindicated. Any degree of hepatic impairment, whether categorized as Child-Pugh Class A, B, or C, serves as a contraindication for Comfrey Root. The liver's inability to maintain normal metabolic processes increases the danger of PA-induced injury, and even a small 'second hit' from comfrey toxins can trigger acute-on-chronic liver failure.
> Important: Special populations require individualized medical assessment to prevent severe adverse outcomes.
| Parameter | Value |
|---|---|
| Bioavailability | <5% (Topical, intact skin); High (Oral - Prohibited) |
| Protein Binding | Unknown |
| Half-life | 2-4 hours (for PAs); damage is cumulative |
| Tmax | 1-2 hours (Topical absorption) |
| Metabolism | Hepatic (CYP3A4) to toxic pyrroles |
| Excretion | Renal (Metabolites) |
Comfrey Root is classified as a Non-Standardized Plant Allergenic Extract [EPC] and a Nitrogen Binding Agent [EPC]. It shares clinical space with other topical anti-inflammatories and allergenic diagnostic agents but is unique due to its specific alkaloid-related toxicity profile.